Antoni Ribas

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 69

Top Venues

Nature communications

Nature genetics

Nature

Nature medicine

University of California Los Angeles Library

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California Los Angeles Library

United States

Professor :: Medicine

Publications

Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas
Correction: ERK mediates interferon gamma-induced melanoma cell death. Molecular cancer 23 (1) (2024)
Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas
Correction: ERK mediates interferon gamma-induced melanoma cell death. Molecular cancer 23 (1) (2024)
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia Ming Chen, Daniel Sanghoon Shin, Philip O Scumpia, Roxana A Radu, Yvonne Chen, Antoni Ribas, Cristina Puig-Saus
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes. Nature communications 15 (1) (2024)
Yang Pan, John W Phillips, Beatrice D Zhang, Miyako Noguchi, Eric Kutschera, Jami McLaughlin, Pavlo A Nesterenko, Zhiyuan Mao, Nathanael J Bangayan, Robert Wang, Wendy Tran, Harry Taegyun Yang, Yuanyuan Wang, Yang Xu, Matthew B Obusan, Donghui Cheng, Alex H Lee, Kathryn E Kadash-Edmondson, Ameya Champhekar, Cristina Puig-Saus, Antoni Ribas, Robert M Prins, Christopher S Seet, Gay M Crooks, Owen N Witte, Yi Xing
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics (2023)
Christopher A Klebanoff, Smita S Chandran, Brian M Baker, Sergio A Quezada, Antoni Ribas
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome. Nature reviews. Drug discovery (2023)
Vina P Nguyen, Katie M Campbell, Theodore Scott Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga Carretero, Maggie L DiNome, Helena R Chang, Denise K Oseguera, Antoni Ribas, John A Glaspy
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. Cancer research communications 3 (8) (2023)
James R Heath, Daniel G Chen, Jingyi Xie, Jongchan Choi, Rachel H Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Benjamin D Solomon, Katie M Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis L Lanier, Philip Mease, Jason D Goldman, Yapeng Su
An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. Research square (2023)
Luke Frankiw, Arun Singh, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. Journal for immunotherapy of cancer 11 (5) (2023)
Melissa G Lechner, Zikang Zhou, Aline T Hoang, Nicole Huang, Jessica Ortega, Lauren N Scott, Ho-Chung Chen, Anushi Y Patel, Rana Yakhshi-Tafti, Kristy Kim, Willy Hugo, Pouyan Famini, Alexandra Drakaki, Antoni Ribas, Trevor E Angell, Maureen A Su
Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. Science translational medicine 15 (696) (2023)
Melissa G Lechner, Zikang Zhou, Aline T Hoang, Nicole Huang, Jessica Ortega, Lauren N Scott, Ho-Chung Chen, Anushi Y Patel, Rana Yakhshi-Tafti, Kristy Kim, Willy Hugo, Pouyan Famini, Alexandra Drakaki, Antoni Ribas, Trevor E Angell, Maureen A Su
Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. Science translational medicine 15 (696) (2023)
Yang Pan, John W Phillips, Beatrice D Zhang, Miyako Noguchi, Eric Kutschera, Jami McLaughlin, Pavlo A Nesterenko, Zhiyuan Mao, Nathanael J Bangayan, Robert Wang, Wendy Tran, Harry Taegyun Yang, Yuanyuan Wang, Yang Xu, Matthew B Obusan, Donghui Cheng, Alex H Lee, Kathryn E Kadash-Edmondson, Ameya Champhekar, Cristina Puig-Saus, Antoni Ribas, Robert M Prins, Christopher S Seet, Gay M Crooks, Owen N Witte, Yi Xing
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Guy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, Glenn Begley, Michael Cecchini, Joseph Paul Eder, François Ghiringhelli, Antoine Italiano, Marina Kochetkova, Rong Li, Fatima Mechta-Grigoriou, Sara I Pai, Paolo Provenzano, Ellen Puré, Antoni Ribas, Kurt A Schalper, Wolf Herman Fridman
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. Journal for immunotherapy of cancer 11 (6) (2023)
Ari M VanderWalde, Shay L Bellasea, Kari L Kendra, Nikhil I Khushalani, Katie M Campbell, Philip O Scumpia, Lawrence F Kuklinski, Frances Collichio, Jeffrey A Sosman, Alexandra P Ikeguchi, Adrienne I Victor, Thach-Giao Truong, Bartosz Chmielowski, David C Portnoy, Yuanbin Chen, Kim A Margolin, Charles Bane, Constantin A Dasanu, Douglas B Johnson, Zeynep Eroglu, Sunandana Chandra, Egmidio Medina, Cynthia R Gonzalez, Ignacio Baselga-Carretero, Agustin Vega-Crespo, Ivan Perez Garcilazo, Elad Sharon, Siwen Hu-Lieskovan, Sapna Pradyuman Patel, Kenneth F Grossmann, James Moon, Michael C Wu, Antoni Ribas
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial. Nature medicine (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics 55 (1) (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics 55 (1) (2023)
Luke Frankiw, Arun Singh, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. Journal for immunotherapy of cancer 11 (5) (2023)
Theodore Scott Nowicki, Cole W Peters, Crystal Quiros, Conner K Kidd, Moe Kawakami, Alexandra M Klomhaus, Ignacio Baselga Carretero, Paula Kaplan-Lefko, Mignonette H Macabali, Ivan Perez Garcilazo, Beata Berent-Maoz, Begoña Comin-Anduix, Antoni Ribas
Infusion Product TNFα, Th2, and STAT3 Activities are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy. Cancer immunology research (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics 55 (1) (2023)
Huiming Xia, Joshua F McMichael, Michelle Becker-Hapak, Onyinyechi C Onyeador, Rico Buchli, Ethan McClain, Patrick Pence, Suangson Supabphol, Megan M Richters, Anamika Basu, Cody A Ramirez, Cristina Puig-Saus, Kelsy C Cotto, Sharon L Freshour, Jasreet Hundal, Susanna Kiwala, S Peter Goedegebuure, Tanner M Johanns, Gavin P Dunn, Antoni Ribas, Christopher A Miller, William E Gillanders, Todd A Fehniger, Malachi Griffith, Malachi Griffith
Computational prediction of MHC anchor locations guides neoantigen identification and prioritization. Science immunology 8 (82) (2023)
Cristina Puig-Saus, Barbara Sennino, Songming Peng, Clifford L Wang, Zheng Pan, Benjamin Yuen, Bhamini Purandare, Duo An, Boi B Quach, Diana Nguyen, Huiming Xia, Sameeha Jilani, Kevin Shao, Claire McHugh, John Greer, Phillip Peabody, Saparya Nayak, Jonathan Hoover, Sara Said, Kyle Jacoby, Olivier Dalmas, Susan P Foy, Andrew Conroy, Michael C Yi, Christine Shieh, William Lu, Katharine Heeringa, Yan Ma, Shahab Chizari, Melissa J Pilling, Marc Ting, Ramya Tunuguntla, Salemiz Sandoval, Robert Moot, Theresa Hunter, Sidi Zhao, Justin D Saco, Ivan Perez-Garcilazo, Egmidio Medina, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Gabriel Abril-Rodriguez, Grace Cherry, Deborah J Wong, Jasreet Hundal, Bartosz Chmielowski, Daniel E Speiser, Michael T Bethune, Xiaoyan R Bao, Alena Gros, Malachi Griffith, Malachi Griffith, James R Heath, Alex Franzusoff, Stefanie J Mandl, Antoni Ribas
Neoantigen-targeted CD8 + T cell responses with PD-1 blockade therapy. Nature 615 (7953) (2023)
Prashanthi Dharanipragada, Xiao Zhang, Sixue Liu, Shirley H Lomeli, Aayoung Hong, Yan Wang, Zhentao Yang, Kara Z Lo, Agustin Vega-Crespo, Antoni Ribas, Stergios J Moschos, Gatien Moriceau, Roger S Lo
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. Cancer discovery (2023)
Cristina Puig-Saus, Barbara Sennino, Songming Peng, Clifford L Wang, Zheng Pan, Benjamin Yuen, Bhamini Purandare, Duo An, Boi B Quach, Diana Nguyen, Huiming Xia, Sameeha Jilani, Kevin Shao, Claire McHugh, John Greer, Phillip Peabody, Saparya Nayak, Jonathan Hoover, Sara Said, Kyle Jacoby, Olivier Dalmas, Susan P Foy, Andrew Conroy, Michael C Yi, Christine Shieh, William Lu, Katharine Heeringa, Yan Ma, Shahab Chizari, Melissa J Pilling, Marc Ting, Ramya Tunuguntla, Salemiz Sandoval, Robert Moot, Theresa Hunter, Sidi Zhao, Justin D Saco, Ivan Perez-Garcilazo, Egmidio Medina, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Gabriel Abril-Rodriguez, Grace Cherry, Deborah J Wong, Jasreet Hundal, Bartosz Chmielowski, Daniel E Speiser, Michael T Bethune, Xiaoyan R Bao, Alena Gros, Malachi Griffith, Malachi Griffith, James R Heath, Alex Franzusoff, Stefanie J Mandl, Antoni Ribas
Neoantigen-targeted CD8 + T cell responses with PD-1 blockade therapy. Nature 615 (7953) (2023)
Davis Y Torrejon, Mildred Galvez, Gabriel Abril-Rodriguez, Katie M Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comin-Anduix, Antoni Ribas
Antitumor Immune Responses in B2M-Deficient Cancers. Cancer immunology research (2023)
Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas
ERK mediates interferon gamma-induced melanoma cell death. Molecular cancer 22 (1) (2023)
Yang Pan, John W Phillips, Beatrice D Zhang, Miyako Noguchi, Eric Kutschera, Jami McLaughlin, Pavlo A Nesterenko, Zhiyuan Mao, Nathanael J Bangayan, Robert Wang, Wendy Tran, Harry Taegyun Yang, Yuanyuan Wang, Yang Xu, Matthew B Obusan, Donghui Cheng, Alex H Lee, Kathryn E Kadash-Edmondson, Ameya Champhekar, Cristina Puig-Saus, Antoni Ribas, Robert M Prins, Christopher S Seet, Gay M Crooks, Owen N Witte, Yi Xing
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Cristina Puig-Saus, Barbara Sennino, Songming Peng, Clifford L Wang, Zheng Pan, Benjamin Yuen, Bhamini Purandare, Duo An, Boi B Quach, Diana Nguyen, Huiming Xia, Sameeha Jilani, Kevin Shao, Claire McHugh, John Greer, Phillip Peabody, Saparya Nayak, Jonathan Hoover, Sara Said, Kyle Jacoby, Olivier Dalmas, Susan P Foy, Andrew Conroy, Michael C Yi, Christine Shieh, William Lu, Katharine Heeringa, Yan Ma, Shahab Chizari, Melissa J Pilling, Marc Ting, Ramya Tunuguntla, Salemiz Sandoval, Robert Moot, Theresa Hunter, Sidi Zhao, Justin D Saco, Ivan Perez-Garcilazo, Egmidio Medina, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Gabriel Abril-Rodriguez, Grace Cherry, Deborah J Wong, Jasreet Hundal, Bartosz Chmielowski, Daniel E Speiser, Michael T Bethune, Xiaoyan R Bao, Alena Gros, Malachi Griffith, Malachi Griffith, James R Heath, Alex Franzusoff, Stefanie J Mandl, Antoni Ribas
Neoantigen-targeted CD8 + T cell responses with PD-1 blockade therapy. Nature (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics 55 (1) (2023)
Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer A Khan, Brian S Henick, Antoni Ribas, Evan Z Macosko, Fei Chen, Alison M Taylor, Gary K Schwartz, Richard D Carvajal, Elham Azizi, Benjamin Izar
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics 55 (1) (2023)
Caroline Robert, Matteo S Carlino, Catriona McNeil, Antoni Ribas, Jean-Jacques Grob, Jacob Schachter, Marta Nyakas, Damien Kee, Teresa M Petrella, Arnold Blaustein, Michal Lotem, Ana Arance, Adil I Daud, Omid Hamid, James M G Larkin, James Anderson, Clemens Krepler, Dmitri Grebennik, Georgina V Long
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Melissa G Lechner, Zikang Zhou, Aline T Hoang, Nicole Huang, Jessica Ortega, Lauren N Scott, Ho-Chung Chen, Anushi Y Patel, Rana Yakhshi-Tafti, Kristy Kim, Willy Hugo, Pouyan Famini, Alexandra Drakaki, Antoni Ribas, Trevor E Angell, Maureen A Su
Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. Science translational medicine 15 (696) (2023)
Sarah M Larson, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin M Harris, Mobina Khericha, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Melanie Ayala Ceja, Martin S Allen-Auerbach, Jonathan W Said, Karla Nawaly, Monica Mead, Sven de Vos, Patricia A Young, Caspian Oliai, Gary J Schiller, John M Timmerman, Antoni Ribas, Yvonne Y Chen
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer discovery (2022)
Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen, Thach-Giao Truong, Helen H Moon, Diwakar Davar, Mark Allen O'Rourke, Joseph J Stephenson, Brendan D Curti, Walter J Urba, Joanna M Brell, Pauline Funchain, Kari L Kendra, Alexandra P Ikeguchi, Anthony Jaslowski, Charles L Bane, Mark A Taylor, Madhuri Bajaj, Robert M Conry, Robert J Ellis, Theodore F Logan, Noel Laudi, Jeffrey A Sosman, David G Crockett, Andrew L Pecora, Ian J Okazaki, Sowjanya Reganti, Sunandana Chandra, Samantha Guild, Helen X Chen, Howard Z Streicher, Jedd D Wolchok, Antoni Ribas, Joanne M Jeter
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Susan P Foy, Kyle Jacoby, Daniela A Bota, Theresa Hunter, Zheng Pan, Eric Stawiski, Yan Ma, William Lu, Songming Peng, Clifford L Wang, Benjamin Yuen, Olivier Dalmas, Katharine Heeringa, Barbara Sennino, Andy Conroy, Michael T Bethune, Ines Mende, William White, Monica Kukreja, Swetha Gunturu, Emily Humphrey, Adeel Hussaini, Duo An, Adam J Litterman, Boi Bryant Quach, Alphonsus H C Ng, Yue Lu, Chad Smith, Katie M Campbell, Daniel Anaya, Lindsey Skrdlant, Eva Yi-Hsuan Huang, Ventura Mendoza, Jyoti Mathur, Luke Dengler, Bhamini Purandare, Robert Moot, Michael C Yi, Roel Funke, Alison Sibley, Todd Stallings-Schmitt, David Y Oh, Bartosz Chmielowski, Mehrdad Abedi, Yuan Yuan, Jeffrey A Sosman, Sylvia M Lee, Adam J Schoenfeld, David Baltimore, James R Heath, Alex Franzusoff, Antoni Ribas, Arati V Rao, Stefanie J Mandl
Non-viral precision T cell receptor replacement for personalized cell therapy. Nature (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Anusha Kalbasi, Mikko Siurala, Leon L Su, Mito Tariveranmoshabad, Lora K Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V Kremer, Amy L Sun, María Sofía Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C Rommel, Enrico Radaelli, Regina M Young, Warren J Leonard, Antoni Ribas, Carl H June, K Christopher Garcia
Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature 607 (7918) (2022)
Razvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, Andrew Albright, Julie Kobie, Lingkang Huang, Qing Zhao, Anran Wang, Hua Ma, Z Alexander Cao, Michael Morrissey, Antoni Ribas, Petros D Grivas, David W Cescon, Terrill K McClanahan, Alexandra Snyder, Mark Ayers, Jared Lunceford, Andrey Loboda
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Melissa G Lechner, Mandy I Cheng, Anushi Y Patel, Aline T Hoang, Natalie Yakobian, Michael Astourian, Marissa S Pioso, Eduardo D Rodriguez, Ethan C McCarthy, Willy Hugo, Trevor E Angell, Alexandra Drakaki, Antoni Ribas, Maureen A Su
Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy. Journal of immunology (Baltimore, Md. : 1950) 209 (4) (2022)
Antoni Ribas, W Nicholas Haining, Ton N M Schumacher
When Cancer Cells Become the Enablers of an Antitumor Immune Response. Cancer discovery 12 (10) (2022)
Jason A Chesney, Antoni Ribas, Georgina V Long, Joanne M Jeter, Reinhard Dummer, Igor Puzanov, Christoph Hoeller, Thomas F Gajewski, Ralf Gutzmer, Piotr Lukasz Rutkowski, Lev Demidov, Petr Arenberger, Sang Joon Shin, Pier Francesco Ferrucci, Andrew M Haydon, John R Hyngstrom, Johannes V van Thienen, Sebastian Haferkamp, Josep Malvehy Guilera, Bernardo Leon Rapoport, Ari M VanderWalde, Scott J Diede, James R Anderson, Sheryl Treichel, Edward L Chan, Sumita Bhatta, Jennifer Gansert, Frank Stephen Hodi, Helen J Gogas
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith A McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro, Paolo Antonio Ascierto
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future oncology (London, England) 18 (17) (2022)
Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Sarah V Kremer, Katie M Campbell, Juan M Funes, Agustin Vega-Crespo, Giulia Parisi, Ameya Champekar, Christine Nguyen, Davis Y Torrejon, Daniel Sanghoon Shin, Jesse M Zaretsky, Robert D Damoiseaux, Daniel E Speiser, Pedro P López-Casas, Marisol Quintero, Antoni Ribas
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Science translational medicine 12 (565) (2021)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 12 (1) (2021)
Jasper Z Williams, Greg M Allen, Devan Shah, Igal S Sterin, Ki H Kim, Vivian P Garcia, Gavin E Shavey, Wei Yu, Cristina Puig-Saus, Jennifer Tsoi, Antoni Ribas, Kole T Roybal, Wendell A Lim
Precise T cell recognition programs designed by transcriptionally linking multiple receptors. Science (New York, N.Y.) 370 (6520) (2021)
Kenneth F Grossmann, Megan Othus, Sapna Pradyuman Patel, Ahmad A Tarhini, Vernon K Sondak, Michael V Knopp, Teresa M Petrella, Thach-Giao Truong, Nikhil I Khushalani, Justine V Cohen, Elizabeth I Buchbinder, Kari L Kendra, Pauline Funchain, Karl D Lewis, Robert M Conry, Bartosz Chmielowski, Ragini R Kudchadkar, Douglas B Johnson, Hongli Li, James Moon, Zeynep Eroglu, Brian Gastman, Magdalena Kovacsovics-Bankowski, Krishna S Gunturu, Scot W Ebbinghaus, Sama Ahsan, Nageatte Ibrahim, Elad Sharon, Larissa A Korde, Joanne M Jeter, Antoni Ribas
Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma. Cancer discovery (2021)
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D Gore, Ronald Levy, Lee M Greenberger
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies. Blood cancer discovery 2 (6) (2021)
Anastasia Gangaev, Elisa A Rozeman, Maartje W Rohaan, Olga I Isaeva, Daisy Philips, Sanne Patiwael, Joost H van den Berg, Antoni Ribas, Dirk Schadendorf, Bastian Schilling, Ton N M Schumacher, Christian U Blank, John B A G Haanen, Pia Kvistborg
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response. Proceedings of the National Academy of Sciences of the United States of America 118 (43) (2021)
Amy L Cummings, Jaklin Gukasyan, Henry Y Lu, Tristan Grogan, Gemalene Sunga, Charlene Marie Fares, Nicholas Hornstein, Jesse Zaretsky, James Carroll, Benjamin Bachrach, Wisdom O Akingbemi, Debory Li, Zorawar Noor, Aaron Lisberg, Jonathan W Goldman, David Elashoff, Alex A T Bui, Antoni Ribas, Steven M Dubinett, Maura Rossetti, Edward B Garon
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44. Nature cancer 1 (12) (2020)
Yapeng Su, Melissa E Ko, Hanjun Cheng, Ronghui Zhu, Min Xue, Jessica K Wang, Jihoon W Lee, Luke Frankiw, Alexander Xu, Stephanie Wong, Lidia Robert, Kaitlyn Takata, Dan Yuan, Yue Lu, Sui Huang, Antoni Ribas, Raphael Levine, Garry P Nolan, Wei Wei, Sylvia K Plevritis, Guideng Li, David Baltimore, James R Heath
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line. Nature communications 11 (1) (2020)
Giulia Parisi, Justin D Saco, Felix B Salazar, Jennifer Tsoi, Paige Krystofinski, Cristina Puig-Saus, Ruixue Zhang, Jing Zhou, Gardenia C Cheung-Lau, Alejandro J Garcia, Catherine S Grasso, Richard Tavaré, Siwen Hu-Lieskovan, Sean Mackay, Jonathan Zalevsky, Chantale Bernatchez, Adi Diab, Anna M Wu, Begoña Comin-Anduix, Deborah Charych, Antoni Ribas
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist. Nature communications 11 (1) (2020)
Reinhard Dummer, Celeste Lebbé, Victoria Atkinson, Mario Mandalà, Paul D Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A Tawbi, Paolo Antonio Ascierto, Antoni Ribas, Keith T Flaherty, Neha Pakhle, Catarina D Campbell, Daniel Gusenleitner, Aisha Masood, Jan C Brase, Eduard Gasal, Georgina V Long
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nature medicine 26 (10) (2020)
Alain Patrick Algazi, Megan K D Othus, Adil I Daud, Roger S Lo, Janice M Mehnert, Thach-Giao Truong, Robert Conry, Kari Kendra, Gary C Doolittle, Joseph I Clark, Michael J Messino, Dennis F Moore, Christopher Lao, Bryan A Faller, Rangaswamy Govindarajan, Amy Harker-Murray, Luke Dreisbach, James Moon, Kenneth F Grossmann, Antoni Ribas
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nature medicine 26 (10) (2020)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 11 (1) (2020)
Jiajun Du, Yapeng Su, Chenxi Qian, Dan Yuan, Kun Miao, Dongkwan Lee, Alphonsus H C Ng, Reto S Wijker, Antoni Ribas, Raphael D Levine, James R Heath, Lu Wei
Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells. Nature communications 11 (1) (2020)
Nicolaos Jay Palaskas, Jacob David Garcia, Roksana Shirazi, Daniel Sanghoon Shin, Cristina Puig-Saus, Daniel Braas, Antoni Ribas, Thomas Glen Graeber
Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesis. Cell discovery 5 (2019)
Paolo Antonio Ascierto, Pier Francesco Ferrucci, Rosalie Fisher, Michele Del Vecchio, Victoria Atkinson, Henrik Schmidt, Jacob Schachter, Paola Queirolo, Georgina V Long, Anna Maria Di Giacomo, Inge Marie Svane, Michal Lotem, Gil Bar-Sela, Felix Couture, Bijoyesh Mookerjee, Razi Ghori, Nageatte Ibrahim, Blanca Homet Moreno, Antoni Ribas
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Nature medicine 25 (6) (2019)
Antoni Ribas, Donald Lawrence, Victoria Atkinson, Sachin Agarwal, Wilson H Miller, Matteo S Carlino, Rosalie Fisher, Georgina V Long, F Stephen Hodi, Jennifer Tsoi, Catherine S Grasso, Bijoyesh Mookerjee, Qing Zhao, Razi Ghori, Blanca Homet Moreno, Nageatte Ibrahim, Omid Hamid
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma. Nature medicine 25 (6) (2019)
Anusha Kalbasi, Antoni Ribas
Tumour-intrinsic resistance to immune checkpoint blockade. Nature reviews. Immunology 20 (1) (2019)
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, Jesse M Zaretsky, Theodore S Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J Quist, Alejandro J Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoña Comin-Anduix, Siwen Hu-Lieskovan, Cun-Yu Wang, Catherine S Grasso, Antoni Ribas
PAK4 inhibition improves PD-1 blockade immunotherapy. Nature cancer 1 (1) (2019)
Jonathan T Sockolosky, Eleonora Trotta, Giulia Parisi, Lora K Picton, Leon L Su, Alan C Le, Akanksha Chhabra, Stephanie L Silveria, Benson M George, Indigo C King, Matthew R Tiffany, Kevin M Jude, Leah V Sibener, Julien S Baker, Judith A Shizuru, Antoni Ribas, Jeffrey A Bluestone, K Christopher Garcia
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science (New York, N.Y.) 359 (6379) (2018)
Razvan Cristescu, Robin Mogg, Mark Ayers, Andrew Albright, Erin Murphy, Jennifer Yearley, Xinwei Sher, Xiao Qiao Liu, Hongchao Lu, Michael Nebozhyn, Chunsheng Zhang, Jared K Lunceford, Andrew Joe, Jonathan Cheng, Andrea L Webber, Nageatte Ibrahim, Elizabeth R Plimack, Patrick A Ott, Tanguy Y Seiwert, Antoni Ribas, Terrill K McClanahan, Joanne E Tomassini, Andrey Loboda, David Kaufman
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science (New York, N.Y.) 362 (6411) (2018)
Antoni Ribas, Jedd D Wolchok
Cancer immunotherapy using checkpoint blockade. Science (New York, N.Y.) 359 (6382) (2018)

Antoni Ribas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antoni Ribas